Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?

FHLC captures the whole healthcare opportunity at rock-bottom cost. XPH narrows the bet to pharmaceuticals and charges significantly more for it.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at fool.com →

More in Health & Medicine

More from Thursday 10 September →